Rtw-Investments-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
68
Total Value
6538371722
Accession Number
0001493215-25-000003
Form Type
13F-HR
Manager Name
Rtw-Investments-Lp
Data Enrichment
93% identified
63 identified5 unidentified

Holdings

68 positions • $6.5B total value
Manager:
Search and click to pin securities to the top
Page 2 of 4
Zai Lab Ltd
Shares:3.1M
Value:$113.4M
% of Portfolio:1.7% ($113.4M/$6.5B)
CYTOKINETICS INC
Shares:2.7M
Value:$109.4M
% of Portfolio:1.7% ($109.4M/$6.5B)
ESTABLISHMENT LABS HOLDINGS INC.
Shares:2.6M
Value:$105.4M
% of Portfolio:1.6% ($105.4M/$6.5B)
Apogee Therapeutics, Inc.
Shares:2.7M
Value:$101.3M
% of Portfolio:1.5% ($101.3M/$6.5B)
INTUITIVE SURGICAL INC
Shares:202.5K
Value:$100.3M
% of Portfolio:1.5% ($100.3M/$6.5B)
GLOBUS MEDICAL INC
Shares:1.1M
Value:$82.3M
% of Portfolio:1.3% ($82.3M/$6.5B)
Ultragenyx Pharmaceutical Inc.
Shares:1.7M
Value:$61.8M
% of Portfolio:0.9% ($61.8M/$6.5B)
GH Research PLC
Shares:5.5M
Value:$60.7M
% of Portfolio:0.9% ($60.7M/$6.5B)
Spyre Therapeutics, Inc.
Shares:3.6M
Value:$58.4M
% of Portfolio:0.9% ($58.4M/$6.5B)
uniQure N.V.
Shares:4.3M
Value:$45.2M
% of Portfolio:0.7% ($45.2M/$6.5B)
UroGen Pharma Ltd.
Shares:3.8M
Value:$42.4M
% of Portfolio:0.6% ($42.4M/$6.5B)
GE HealthCare Technologies Inc.
Shares:520.0K
Value:$42.0M
% of Portfolio:0.6% ($42.0M/$6.5B)
CG Oncology, Inc.
Shares:1.7M
Value:$41.7M
% of Portfolio:0.6% ($41.7M/$6.5B)
08659B102
Shares:3.3M
Value:$40.4M
% of Portfolio:0.6% ($40.4M/$6.5B)
Orchestra BioMed Holdings, Inc.
Shares:8.2M
Value:$35.1M
% of Portfolio:0.5% ($35.1M/$6.5B)
Stoke Therapeutics, Inc.
Shares:5.1M
Value:$34.1M
% of Portfolio:0.5% ($34.1M/$6.5B)
Immatics N.V.
Shares:6.9M
Value:$31.2M
% of Portfolio:0.5% ($31.2M/$6.5B)
Taysha Gene Therapies, Inc.
Shares:18.8M
Value:$26.1M
% of Portfolio:0.4% ($26.1M/$6.5B)
Verastem, Inc.
Shares:4.2M
Value:$25.6M
% of Portfolio:0.4% ($25.6M/$6.5B)
Xencor Inc
Shares:2.4M
Value:$25.6M
% of Portfolio:0.4% ($25.6M/$6.5B)